Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In development
Guidance, NICE advice and quality standards
In development
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (9)
Type
(
2 selected
)
Type
Guidance (370)
NICE advice (1)
Quality standard (12)
Guidance programme
Guidance programme
Clinical guidelines (32)
Diagnostics guidance (6)
Diagnostics guidanceDiagnostics guidance (6)
Health technology evaluations (10)
Highly specialised technologies guidance (10)
Interventional procedures guidance (6)
Interventional procedures guidanceInterventional procedures guidance (23)
Medical technologies guidance (4)
Medical technologies guidanceMedical technologies guidance (9)
NICE guidelines (36)
Public health guidelines (1)
Technology appraisal guidance (265)
Apply filters
Showing 21 to 30 of 382
Sort by
Title
Date
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Atezolizumab for adjuvant treatment of resected high-risk muscle-invasive urothelial cancer [ID2730]
Technology appraisal guidance
TBC
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor [ID6213]
Technology appraisal guidance
TBC
ATIR101 with haploidentical haematopoietic stem cell transplantation for haematological cancers [ID1093]
Technology appraisal guidance
TBC
Atogepant for preventing migraine [ID5090]
Technology appraisal guidance
TBC
Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]
Technology appraisal guidance
TBC
Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]
Technology appraisal guidance
TBC
Avapritinib for treating advanced systemic mastocytosis ID3770
Technology appraisal guidance
TBC
Avelumab for previously treated platinum-resistant ovarian cancer ID1497
Technology appraisal guidance
TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]
Technology appraisal guidance
TBC
AZD 3152 for preventing COVID-19 [ID6282]
Technology appraisal guidance
TBC
Previous page
1
2
Current page
3
4
5
…
39
Page
3
of
39
Next page
Results per page
10
25
50
All
Back to top